Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Testing Earlier for Gestational Diabetes a Smarter Way to Screen Pregnant Women

23.08.2002


Testing pregnant women for gestational diabetes at 16-weeks of pregnancy is a more efficient way to screen for the disease than the current method of screening women during their third trimester, said Gerard Nahum, M.D., an associate clinical professor at Duke University Medical Center’s department of obstetrics and gynecology.



The earlier tests, Nahum said, allow women at highest risk for gestational diabetes to be identified and treated earlier, possibly heading off complications in both mother and baby. He is lead author of a study on the findings that appears in the August 2002 issue of the Journal of Reproductive Medicine.

Obstetricians have usually screened women in their third trimester because most doctors believe that screening later in pregnancy is more accurate. However, he said, “Screening at 16 weeks is a better predictor of gestational diabetes. It’s more sensitive than screening later, and allows us to focus earlier on women who are at greatest risk. It’s also a more practical screening technique because blood samples drawn during early pregnancy for other tests can also be used for this purpose.”


Nahum and colleagues from the University of Hawaii School of Medicine and California State University studied 255 pregnant women who visited a private obstetrics practice in Honolulu.

All of the women were given a glucose screening test between 14 and 18 weeks of pregnancy. At initial screening, 14 of the 255 women had blood plasma glucose levels higher than 135 milligrams of glucose per deciliter of blood (mg/dL) and were sent for additional testing to confirm a gestational diabetes diagnosis.

The remaining 241 women were screened again at between 24 and 32 weeks. At either point, if women tested higher than 135 mg/dL, they were sent for additional formal glucose tolerance testing.

“Women who had a 16-week glucose screening test result of less than 110 mg/dL had a 99.4 percent chance of not developing gestational diabetes,” said Nahum. “None of the women who had a result of less than 104 mg/dL developed gestational diabetes. This gives us a cutoff point. Women who test in this range at 16 weeks are almost guaranteed not to develop gestational diabetes.”

Nahum said that for women who fall in the intermediate range (111 mg/dL to 134 mg/dL) at 16 weeks, a repeat glucose screening test should be given at 28 weeks to assess whether the woman should be sent for more in-depth testing.

While it is a natural assumption to say that earlier screenings should lead to better outcomes for mother and baby, Nahum said more studies are needed to confirm that.
“We don’t know how earlier diagnosis of gestational diabetes will impact maternal-fetal outcomes because we didn’t examine that in this study, but that is certainly something to focus on in future research,” he said.

Gestational diabetes occurs in 2 percent to 7 percent of all pregnancies in the United States. It develops when a pregnant woman is not able to produce enough insulin to keep her blood sugar, also known as glucose, within a normal range that is safe for her and her developing baby.

Complications from gestational diabetes include above-average weight gain for the baby that can result in injury to the nerves in the baby’s neck from a difficult delivery, an increased risk of newborn fractures, a higher likelihood of fetal distress and possible hypoglycemia, jaundice or breathing problems in the baby.

Changes in diet and exercise are usually enough to help keep blood sugar levels within the normal range, but in some cases insulin injections are needed. Most women who develop diabetes during pregnancy go back to having normal glucose tolerance after the birth of the baby; however, these women may be at greater risk for adult onset diabetes mellitus later in life.

Co-authors include Stephen B. Wilson, M.D., University of Hawaii School of Medicine; and Harold Stanislaw, Ph.D., California State University.

Amy Austell | EurekAlert!
Further information:
http://dukemednews.org/
http://hawaiimed.hawaii.edu/
http://www.csustan.edu/

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Long-lived storage of a photonic qubit for worldwide teleportation

12.12.2017 | Physics and Astronomy

Multi-year submarine-canyon study challenges textbook theories about turbidity currents

12.12.2017 | Earth Sciences

Electromagnetic water cloak eliminates drag and wake

12.12.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>